In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...

Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval.

Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...

Today, I'm going to talk about clinical concerns that I think both our patients and we have been having about sensors. First of all, there was a recall of some of the Freestyle Libre 3 Plus devices, ...

Education Cabinet Secretary Julius Ogamba and Principal Secretary Julius Bitok during the release of KJSEA results in Nairobi. [File, Standard] The placement of the first cohort of learners to senior ...

Streaming services already cut up their content with annoying and often poorly-timed ads. Now, thanks to new tech, your favorite movies and TV shows could soon be stuffed with AI-generated product ...

When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experiment: He wore the new biosensor and the previous generation at ...

Candice was diagnosed with Type 1 diabetes at 17. For more than two decades, Candice Davis has been a steady presence within Jay-Z’s growing empire. She started at Baseline Studios in 2002, where she ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

Dexcom has won FDA clearance of the Smart Basal, a CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy. The clearance ...